Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Nov;6(5):434–436. doi: 10.1111/j.1365-2125.1978.tb04610.x

Drug interactions with warfarin enantiomers--a different perspective.

L B Wingard Jr, G Levy
PMCID: PMC1429563  PMID: 728289

Full text

PDF
434

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breckenridge A., Orme M. L. The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats. Life Sci II. 1972 Apr 8;11(7):337–345. doi: 10.1016/0024-3205(72)90073-2. [DOI] [PubMed] [Google Scholar]
  2. Breckenridge A., Orme M., Wesseling H., Lewis R. J., Gibbons R. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther. 1974 Apr;15(4):424–430. doi: 10.1002/cpt1974154424. [DOI] [PubMed] [Google Scholar]
  3. Chan K. K., Lewis R. J., Trager W. F. Absolute configurations of the four warfarin alcohols. J Med Chem. 1972 Dec;15(12):1265–1270. doi: 10.1021/jm00282a016. [DOI] [PubMed] [Google Scholar]
  4. Hewick D. S., McEwen J. Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man. J Pharm Pharmacol. 1973 Jun;25(6):458–465. doi: 10.1111/j.2042-7158.1973.tb09133.x. [DOI] [PubMed] [Google Scholar]
  5. Hewick D. S. The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats. J Pharm Pharmacol. 1972 Aug;24(8):661–662. doi: 10.1111/j.2042-7158.1972.tb09083.x. [DOI] [PubMed] [Google Scholar]
  6. Lewis R. J., Trager W. F., Chan K. K., Breckenridge A., Orme M., Roland M., Schary W. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest. 1974 Jun;53(6):1607–1617. doi: 10.1172/JCI107711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. O'Reilly R. A. Studies on the optical enantiomorphs of warfarin in man. Clin Pharmacol Ther. 1974 Aug;16(2):348–354. doi: 10.1002/cpt1974162348. [DOI] [PubMed] [Google Scholar]
  8. O'Reilly R. A. The stereoselective interaction of warfarin and metronidazole in man. N Engl J Med. 1976 Aug 12;295(7):354–357. doi: 10.1056/NEJM197608122950702. [DOI] [PubMed] [Google Scholar]
  9. Wingard L. B., Jr, Levy G. Comparative pharmacokinetics of coumarin anticoagulants XXXVI: Predicted steady-state patterns of prothrombin complex activity produced by equieffective doses of (R)-(+)- and (S)-(-)-warfarin in humans. J Pharm Sci. 1977 Dec;66(12):1790–1791. doi: 10.1002/jps.2600661240. [DOI] [PubMed] [Google Scholar]
  10. Wingard L. B., Jr, O'Reilly R. A., Levy G. Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations. Clin Pharmacol Ther. 1978 Feb;23(2):212–217. doi: 10.1002/cpt1978232212. [DOI] [PubMed] [Google Scholar]
  11. Yacobi A., Levy G. Pharmacokinetics of the warfarin enantiomers in rats. J Pharmacokinet Biopharm. 1974 Jun;2(3):239–255. doi: 10.1007/BF01059764. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES